SecBot SecBot
8-K ·Filed Jun 30, 2026

KRMD

KORU Medical Systems, Inc.
NEUTRAL
Impact 3/10
Horizonmonths Processed3mo ago SEC0001161697-26-000139
8-K Item 1.01 + 5.02 (likely routine officer/director compensation agreement)
Actionable Insight • Neutral

Monitor for the second manufacturing site qualification milestone by December 31, 2027, which provides KORU with a termination right. The extended term through 2031 signals supply chain stability but lacks financial detail to assess margin impact.

DirectionNeutral
Confidencemedium
Horizonmonths
Final — all horizons settled through T+60d
KRMD ▼ -25.68% at T+60d
NEUTRAL call -25.68% · α vs SPY -28.55% · entry $4.40 → $3.27
Entry = T+0 close
Jun 30, 2026
via day close
T+1d
+2.05%
call +2.05% · α +2.18%
$4.49
settled 4mo ago
T+5d
+4.32%
call +4.32% · α +4.06%
$4.59
settled 4mo ago
T+20d
-7.50%
call -7.50% · α -5.31%
$4.07
settled 3mo ago
T+60d
-25.68%
call -25.68% · α -28.55%
$3.27
settled 5w ago

Price Chart

Loading chart...

Executive Summary

KORU Medical Systems amended its manufacturing and supply agreement with Command Medical Products, extending the term through December 31, 2031, and adding a second manufacturing site requirement. All financial terms (pricing, volume targets, true-up formulas) remain redacted as confidential, so no quantifiable financial impact is disclosed.

Key Facts

  • Initial term extended from 3 years to 8 years, now expiring December 31, 2031
  • Command must qualify a second manufacturing site by December 31, 2027 or face termination
  • Command granted exclusive manufacturing rights for HighFlo and Precision Flow products only
  • Non-competition provision removed from the agreement
  • Intellectual property ownership and licensing terms clarified
  • All pricing, volume targets, and true-up formulas remain redacted as confidential

Financial Impact

No financial figures disclosed; all pricing, volume targets, and true-up mechanisms redacted as confidential

Risk Factors

  • Failure to qualify second manufacturing site could disrupt supply chain
  • Removal of non-compete may allow Command to work with competitors
  • Redacted pricing prevents assessment of cost trends or margin pressure

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
82% bullish (11 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001161697-26-000139
Document: form_8-k.htm0001161697-26-000139
Document: 0001161697-26-000139-index-headers.html0001161697-26-000139
Document: 0001161697-26-000139-index.html0001161697-26-000139
Document: 0001161697-26-000139.txt0001161697-26-000139
7 reports for KRMD
Performance horizon
67% Hit rate @ T+5 2 of 3 directional calls Went positive at some point 2 of 3 best @ T+5▲ +0.97%May 20, 2026
Filters
Rows
Reports for KRMD — sortable, filterable
TypeNow
Jul 9, 2026
15w ago
Institutional Cluster
NEUTRAL ★ 4/10
$4.43 $4.24▼ −4.29%▼ −4.16%$3.12 (−29.57%)
Jun 30, 2026
16w ago
8-K
NEUTRAL ★ 3/10
$4.40 $4.59▲ +4.32%▲ +4.06%$3.12 (−29.09%)
May 20, 2026
22w ago
Insider Cluster
BULLISH ★ 7/10
$4.14 $4.18▲ +0.97%▼ −0.63%$3.12 (−24.64%)
May 20, 2026
22w ago
Insider Cluster
BULLISH ★ 7/10
$4.14 $4.06▼ −1.93%▼ −3.78%$3.12 (−24.64%)
May 20, 2026
22w ago
Insider Cluster
BULLISH ★ 7/10
$4.14 $4.18▲ +0.97%▼ −0.63%$3.12 (−24.64%)
May 18, 2026
23w ago
Insider Cluster
NEUTRAL ★ 2/10
$3.96 $4.15▲ +4.80%▲ +2.50%$3.12 (−21.21%)
May 6, 2026
24w ago
8-K
MIXED ★ 5/10
$4.44 $3.85▼ −13.29%▼ −14.79%$3.12 (−29.73%)
Showing 7 of 7

US Market Status

Market Closed — Opens in 1h 52m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 30, 2026